Equity Components [Axis]
Series C Redeemable Preferred Stock [Member]
Class of Stock [Axis]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Geographical [Axis]
UNITED STATES
AUSTRALIA
CANADA
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Long-Lived Tangible Asset [Axis]
Office Equipment [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Equity Distribution Agreement [Member]
Antidilutive Securities [Axis]
Warrants to Purchase Shares of Common Stock [Member]
Restricted Stock Units Vested and Unissued [Member]
Restricted Stock Units Unvested [Member]
Investment Options to Purchase Shares of Common Stock [Member]
Options to Purchase Shares of Common Stock [Member]
Lab Equipment [Member]
Computer Equipment and Leasehold Improvements [Member]
Related and Nonrelated Parties [Axis]
Related Party [Member]
Distribution Agreement [Member]
Legal Entity [Axis]
Canaccord Genuity LLC [Member]
Class of Warrant or Right [Axis]
February Warrants [Member]
Purchase Agreement [Member]
Registration Rights Agreement [Member]
Purchase Agreements [Member]
Pre-Funded Warrants [Member]
Series A Warrants [Member]
Series B Warrants [Member]
Warrant [Member]
Pre-Funded Warrants and Accompanying Warrants [Member]
Placement Agent Warrants [Member]
Measurement Input Type [Axis]
Measurement Input, Share Price [Member]
Measurement Input, Exercise Price [Member]
Measurement Input, Expected Term [Member]
Measurement Input, Option Volatility [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Expected Dividend Rate [Member]
Series A Warrants and Series B Warrants [Member]
Series C Warrants and Series D Warrants [Member]
Series C Warrants [Member]
Series D Warrants [Member]
Measurement Input, Expected Dividend Payment [Member]
December Inducement Letters [Member]
December Inducement Warrants [Member]
Series E Warrants [Member]
Series F Warrants [Member]
Inducement Warrants [Member]
Warrants [Member]
ATM Agreement [Member]
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
Plan Name [Axis]
2020 Long Term Incentive Plan [Member]
Title and Position [Axis]
Board [Member]
Incentive Plan [Member]
Share-Based Payment Arrangement, Option [Member]
Restricted Stock [Member]
Series C Preferred Stock [Member]
Statement Of Income Location Balance [Axis]
General and Administrative Expenses [Member]
Research and Development Expenses [Member]
Investment Options [Member]
Myco Medica Life Sciences [Member]
Avance Clinical [Member]
Other Consulting and Vendor Agreements [Member]
Income Tax Jurisdiction [Axis]
Domestic Tax Jurisdiction [Member]
State and Local Jurisdiction [Member]
Foreign Tax Jurisdiction [Member]
Securities Purchase Agreement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Sale of Stock [Axis]
Private Placement [Member]
Series G Warrant [Member]
Series H Warrant [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Entity Listing, Par Value Per Share
Auditor Firm ID
Auditor Opinion [Text Block]
Auditor Name
Auditor Location
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash
Prepaid expenses and other current assets
Total current assets
Other assets:
Property and equipment, net
Intangible assets, net
Total other assets
Total assets
LIABILITIES, MEZZANINE EQUITY, AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Due to related parties
Accrued expenses and other current liabilities
Total current liabilities
Commitments and contingencies (Note 9)
Mezzanine equity
Series C redeemable preferred stock, $0.01 par value, 100,000 shares authorized, and 0 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Total mezzanine equity
Shareholders’ equity
Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Common stock, $0.01 par value, 100,000,000 shares authorized, 1,061,533 and 56,501 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities, mezzanine equity, and shareholders’ equity
Statement [Table]
Statement [Line Items]
Temporary equity, par value
Temporary equity, shares authorized
Temporary equity, shares issued
Temporary equity, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Operating expenses
General and administrative
Research and development
Depreciation and amortization
Total operating expenses
Loss from operations
Other income (expense)
Other income
Interest (expense) income, net
Total other income
Net loss before income taxes
Income tax expense
Net loss
Less deemed dividend on inducement of warrants
Net loss attributable to shareholders
Other comprehensive income (loss)
Foreign currency translation
Comprehensive loss
Net loss per share - basic
Net loss per share - diluted
Weighted average shares outstanding, basic
Weighted average shares outstanding, diluted
Balance
Beginning balance, shares
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487, shares
Issuance of common shares for vested RSU
Issuance of common shares for vested RSU, shares
Exercise of Inducement Warrants for common stock
Exercise of Inducement Warrants for Common Stock, shares
Issuance of round up shares
Issuance of round up shares, shares
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs of $217,079
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares
Exercise of Series A, B, C, and D Warrants for common shares, net of offering costs of $988,911
Exercise of Series A and B Warrants for common shares, net of offering costs of $424,659, shares
Deemed dividend on inducement of warrants of $3,359,485
Stock based compensation
Foreign exchange translation loss
Net loss
Common stock sold under the Equity Distribution Agreement, net of offering costs of $583,713
Common Stock sold under the Equity Distribution Agreement, net of offering costs of $583,713, shares
Issuance of direct offering shares (see Note 7)
Issuance of direct offering shares, shares
Proceeds from the subscription receivable related to the issuance of Inducement Warrants, net of offering costs of $12,821
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of common stock in abeyance
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of Common Stock in abeyance, shares
Common stock sold under the Purchase Agreement, net of offering costs of $471,756
Common Stock sold under the Purchase Agreement, net of offering costs, shares
Balance
Balance, shares
Statement of Stockholders' Equity [Abstract]
Net offering costs
Issuance of net offering costs
Warrants offering costs
Inducement of warrants
Common stock equity distribution costs
Proceed from net offering costs
Statement of Cash Flows [Abstract]
Cash Flows From Operating Activities:
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability
Change in fair value of investment option liability
Stock-based compensation
Deferred offering costs expensed
Amortization of intangibles
Depreciation expense
Other
Change in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable, accrued expenses and other liabilities
Due to related parties
Net cash used in operating activities
Cash Flows From Financing Activities:
Proceeds from sale of Common Stock and warrants, net of offering costs
Proceeds from Common Stock sold for cash pursuant to the ATM Agreement, net of offering costs
Proceeds from the exercise and inducement of Series A, B, C, and D warrants, net of offering costs
Proceeds from Common Stock sold under the Equity Distribution Agreement, net of offering costs
Proceeds from Common Stock sold under the Purchase Agreement, net of offering costs
Proceeds from the subscription receivable related to the issuance of Inducement Warrants and the exercise of warrants and preferred investment options
Payment for offering costs previously accrued
Net cash provided by financing activities
Effect of foreign exchange rate on changes on cash
Net increase (decrease) in cash
Cash at beginning of year
Cash at end of year
Supplemental disclosure of cash flow transactions:
Cash paid for interest
Income taxes paid
Non-cash financing and investing activities:
Non-cash issuance of round-up shares
Non-cash issuance of RSA vested shares
Offering costs accrued not paid
Deferred offering costs not paid
Deemed dividend on inducement of warrants
Issuance of Placement Agent Warrants as offering costs
Issuance of common shares for offering costs
Deferred offering costs charged to offering costs
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
No Insider Trading Flag
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS AND LIQUIDITY AND OTHER UNCERTAINTIES
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT
Payables and Accruals [Abstract]
ACCRUED LIABILITIES
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Equity [Abstract]
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS
Licensing Agreements
LICENSING AGREEMENTS
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Income Tax Disclosure [Abstract]
INCOME TAXES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation and Principal of Consolidation
Use of Estimates
Reclassification
Foreign Currency Translation
Cash and Cash Equivalents
Concentration of Credit Risk
Comprehensive Loss
Property & Equipment
Deferred Offering Costs
Modification and Inducement of Warrants
Research and Development
Income Taxes
Stock-Based Compensation
Net Loss per Share
Fair Value of Financial Instruments
Fair Value Measurements
Segment Reporting
Recent Accounting Pronouncements
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS
SCHEDULE OF PROPERTY AND EQUIPMENT NET OF ACCUMULATED DEPRECIATION
SCHEDULE OF ACCRUED LIABILITIES
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
SCHEDULE OF RESTRICTED STOCK UNITS
SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS
SCHEDULE OF WARRANTS OUTSTANDING
SCHEDULE OF INVESTMENT OPTIONS
SCHEDULE OF EARNING (LOSS) BEFORE INCOME TAX
SCHEDULE OF INCOME TAX EXPENSE BENEFITS
SCHEDULE OF EFFECTIVE STATUTORY INCOME TAX RATE
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES
SCHEDULE OF OPERATING LOSS CARRY FORWARDS
Reverse stock split
Reverse stock split conversion
Accumulated deficit
Net cash used in operating activities
Loss from operations
Working capital
Public stock offering
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Cash FDIC insured amount
Estimated useful lives
Deferred offering costs
Unrecognized tax benefits
Restricted stock award shares
Basic and dilutive shares
Operating segments
Prepaid insurance
Prepaid other
Prepaid product development
Prepaid value-added taxes
Total prepaid expenses and other current assets
Property and equipment, gross
Less: Accumulated depreciation
Property and equipment, net of accumulated depreciation
Professional fees
Accrued franchise taxes
Product development
Other
Total accrued liabilities
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Service fees
Service fees paid
Due to related parties, remaining balance
Number of shares, Non-vested beginning
Weighted average fair value, Non-vested beginning
Number of shares, Granted
Weighted average fair value, Granted
Number of shares, Forfeited
Weighted average fair value, Forfeited
Number of shares, vested
Weighted average fair value, Vested
Number of shares, non-vested ending
Weighted average fair value, Non-vested ending
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
StatementOfIncomeLocationBalanceAxis [Axis]
Stock-based compensation expense for RSUs
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant shares outstanding at beginning
Weighted average exercise Price, Outstanding at beginning
Weighted average remaining life, Outstanding
Intrinsic Value, Outstanding beginning
Warrant shares outstanding, Issued
Weighted average exercise price, Issued
Warrant shares outstanding, Exercised
Weighted average exercise price, Exercised
Warrant shares outstanding, Forfeited
Weighted average exercise price, Forfeited
Warrant shares outstanding, Expired
Weighted average exercise price, Expired
Warrant shares outstanding at end
Weighted average exercise Price, Outstanding at end
Intrinsic Value, Outstanding ending
Warrant shares outstanding, Exercisable
Weighted average exercise price, Exercisable
Weighted average remaining life, Exercisable
Intrinsic value, exercisable
Weighted average exercise price, Outstanding beginning
Investment options outstanding, Exercised
Weighted average exercise price, Exercised
Weighted average exercise price, Outstanding end
Intrinsic value, Exercisable
Class of Warrant or Right [Table]
Class of Warrant or Right [Line Items]
Common stock voting rights
Common stock, offering price
Aggregate gross sales price
Commission percentage
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares
Exercise price of warrants
Share price
Warrants issued
Exercise price
Proceeds from inducement warrant
Gross proceeds
Issuance of common shares in exchange for RSU vesting, shares
Aggregate offering price value
Proceeds from common stock
Charged offering costs
Adjustment in additional paid in capital
Offering costs
Purchase committment
Shares resale
Shares commitment
Number of shares traded in market
Deferred offering costs
Assitional deferred charges
Warrants to purchase of shares
Exercise of the warrants
Engagement agreement description
Non-accountable expense allowance
clearing expenses
Shares and pre-funded warrant percentage
Public offering price percentage
Warrant expire date
Fair value of Warrant
Warrants outstanding, measurement input
Expiration term
Stock have been issued due to exercises
Cash proceeds of stock due to exercises
Sale of stock description
Legal fees
Stock have been issued due to exercises
Warrant purchase price
Percentage of placement agent cash fees gross proceeds
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Share Repurchase Program, Remaining Authorized, Number of Shares
Stock based compensation, expenses
Unamortized stock-based compensation costs
Weighted average period
Common stock vested restricted stock units
Redemption price per share
Redeemable preferred stock, shares issued
Redeemable preferred stock, shares outstanding
Preferred Stock authorized for future issuances
LicensingAgreementsTable [Table]
Licensing fee
Milestone payments
Contract cost
Total project costs
Prepaid assets
Accrued liabilities
Research and development expenses
Research and development expense tax credit receivable
Research and development tax credit
Future cash
United States
Foreign
Federal
State
Foreign
Total current income tax (expense) benefit
Federal
State
Foreign
Total deferred income tax (expense) benefit
Total income tax expense
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Income before provision for income taxes
U.S. Federal Statutory Tax Rate at 21%
Federal income tax at the statutory rate, Percentage
Foreign tax rate differential, Percentage
Non-deductible expenses, Percentage
Deferred true-up, Percentage
Changes in Valuation Allowances
Change in valuation allowance, Percentage
Prior Year True Up
Prior Year True Up, Percentage
State Change in Tax Rate
State Change in Tax Rate*, Percentage
State Taxes - Deferred, net of FBOS
State income tax rate (net of federal), Percentage
Other
Other, Percentage
CTA
CTA, Percentage
Other
Other, Percentage
Total Income Tax Provision
Effective income tax rate, Percentage
Federal income tax at the statutory rate
Net operating loss carryforwards
Stock-based compensation
Research and development capitalized expenses
Intangible amortization
Other
Less valuation allowances
Net deferred tax assets
Net operating loss tax carryforwards
Income tax expenses and benefits
Net operating loss carryforwards
Operating loss carryforwards
Valuation allowance
Research and development capitalized gross
Subsequent Event [Table]
Subsequent Event [Line Items]
Number of shares sold
Number of shares sold, per shares
Number of shares sold, value
Warrants issued
Warrant exercise price
Arrangement registration payment
Prepaid research and development.
Accrued franchise taxes.
Accrued product and development cost
Service fees.
Due to related parties remaining balance.
Distribution Agreement [Member]
Canaccord Genuity LLC [Member]
Commission percentage.
Sale of stock consideration expected maximum price on limitation.
February Warrants [Member]
Purchase Agreement [Member]
No Insider Trading Flag.
Registration Rights Agreement [Member]
Stock issued during period commitment shares.
Number of common stock shares traded.
Purchase Agreements [Member]
Common stock equity distribution costs.
Series C Redeemable Preferred Stock [Member]
Deferred offering costs expensed.
Pre-Funded Warrants [Member]
Series A Warrants [Member]
Series B Warrants [Member]
Pre-Funded Warrants and Accompanying Warrants [Member]
Class of warrant or right offering expense.
Engagement agreement description.
Non-accountable expense allowance.
Clearing expenses.
Placement Agent Warrants [Member]
Shares and prefunded warrant percentage.
Public offering price percentage.
Stock issued during period shares exercise of warrants.
Stock issued during period value exercise of warrants.
Series A Warrants and Series B Warrants [Member]
Series C Warrants and Series D Warrants [Member]
Series C Warrants [Member]
Series D Warrants [Member]
Series E Warrants [Member]
Series F Warrants [Member]
Stock issued during period value reverse stock splits.
Stock issued during period value for cash pursuant to ATM agreement.
Stock issued during period shares for cash pursuant to ATM agreement.
Stock issued during period value common stock sold under equity distribution.
Stock issued during period shares common stock sold under equity distribution.
Stock issued during period value issued direct offering net of offering cost.
Stock issued during period shares issued direct offering net of offering cost.
Stock issued common stock sold under the Purchase Agreement, net of offering costs.
Inducement Warrants [Member]
Stock issued common stock sold under the Purchase Agreement, net of offering costs by shares.
Net offering costs.
Stock issued during period shares warrant exercised.
Warrants [Member]
ATM Agreement [Member]
Proceeds from Common Stock sold for cash pursuant to the ATM Agreement, net.
2020 Long Term Incentive Plan [Member]
Board [Member]
Incentive Plan [Member]
Proceed from net offering costs.
Issuance of net offering costs.
Subscription Receivable [Member]
Schedule of warrants outstanding [Table Text Block]
Exercise of warrants for common share.
Exercise of warrants for common stock during period.
Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number.
Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price.
Weighted average exercise price, issued
Weighted average price at which option holders acquired shares when converting their warrants into shares.
Share based compensation arrangements by share based payment award non options forfeited in eriod weighted average exercise price.
Share based compensation arrangements by share based payment award non options exercises in period weighted average expired price.
Warrants, weighted average exercise price.
Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term.
Share based Compensation Arrangement By Share based Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Non Option.
Share-based compensation arrangement by share-based payment award, equity instruments non options, aggregate intrinsic value.
Sharebased compensation arrangement by sharebased payment award equity instruments non options exercisable aggregate intrinsic value nonvested.
Investment Options [Member]
Stock options, outstanding weighted average exercise price.
Share based compensation arrangement by share based payment award non option equity instruments issued in period weighted average exercise price exercised.
Share based Compensation Arrangement By Share based Payment Award Non Options Exercisable Intrinsic Value1,
Licensing Agreements Disclosure [Text Block]
Proceeds from achieving development and sales milestones.
Proceeds from Common Stock sold under the Purchase Agreement, net of offering costs.
Avance Clinical [Member]
Non-cash issuance of RSA vested shares.
Offering costs accrued not paid.
Deferred offering costs not paid.
Deemed dividend on inducement of warrants.
Issuance of Placement Agent Warrants as offering costs.
Issuance of common shares for offering costs
Project costs.
Deferred offering costs charged to offering costs.
Prepaid research and development tax incentive receivable.
Other Consulting and Vendor Agreements [Member]
Research and development capitalized expenses.
Deferred tax assets and intangible amortization.
Effective income tax rate reconciliation deferred trueup.
Working capital.
Deferred Offering Costs [Policy Text Block]
Modification And Inducement Of Warrants [Policy Text Block]
Warrants To Purchase Shares Of Common Stock [Member]
Securities Purchase Agreement [Member]
Series G Warrant [Member]
Series H Warrant [Member]
Income tax reconciliation true up.
Equity Distribution Agreement [Member]
Effective income tax rate reconciliation true up.
General and Administrative Expenses [Member]
Research and Development Expenses [Member]
Myco Medica Life Sciences [Member]
Restricted Stock Units Vested and Unissued [Member]
Restricted Stock Units Unvested [Member]
Investment Options to Purchase Shares of Common Stock [Member]
Options to Purchase Shares of Common Stock [Member]
Computer Equipment and Leasehold Improvements [Member]
Lab Equipment [Member]
December Inducement Letters [Member]
December Inducement Warrants [Member]
Percentage of placement agent cash fees gross proceeds.
Assets, Current
Assets, Noncurrent
Assets
Liabilities, Current
Temporary Equity, Including Noncontrolling Interest
Equity, Attributable to Parent
Liabilities and Equity
Operating Costs and Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Net Income (Loss) Available to Common Stockholders, Basic
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Gain (Loss) on Investments
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Due to Related Parties
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Other Accrued Liabilities, Current
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueNonvested
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedInPeriodWeightedAverageExercisePriceExercised
Current Federal Tax Expense (Benefit)
Current State and Local Tax Expense (Benefit)
Current Foreign Tax Expense (Benefit)
Current Income Tax Expense (Benefit)
Deferred Federal Income Tax Expense (Benefit)
Deferred State and Local Income Tax Expense (Benefit)
Deferred Foreign Income Tax Expense (Benefit)
Deferred Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Effective Income Tax Rate Reconciliation, Percent
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Deferred Tax Assets, Other
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance